Cipla-led Avenue Therapeutics receives CRL from USFDA for IV Tramadol

Share
AuthorPosted at
The FDA did not identify any Chemistry, Manufacturing and Controls issues in the CRL.

from India Infoline News Service https://ift.tt/2SC5mXF
Post a Comment
Labels

Comments